Arif Hussain, Fred Saad, Hiroyoshi Suzuki, Chris Garratt, Margarita Donica, Yingjie Liu, Kentaro Imai, Peter C.C. Fong. "Phase 1/2 OMAHA-U01 substudy 01A: Oral steroidogenesis inhibitor opevesostat alone or in combination with other therapies in participants with metastatic castration-resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5140